ClinicalTrials.gg
Sign In
Drug

Atovaquone clinical trials

Also written Mepron.

studies test it
20
open now
3
in phase 3
3
first study started
2004

Counted the way a researcher would: Atovaquone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Atovaquone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Atovaquone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Nov 1992 · MEPRON · NDA 020259 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Atovaquone
14
Wellvone
2

Brand

Mepron
2

Development codes

566C80
1
BW-566C
1

Studies by the year they started

12 studies that test it; most in 2020 (3)

Studies that test Atovaquone, by start year
YearStudies
20041
20071
20121
20161
20181
20203
20211
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
5
Phase 2
6
Phase 3
3
Phase 4
2
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pneumonia, Pneumocystis
6
HIV Infections
3
COVID-19
2
Leukemia, Myeloid, Acute
1
Bacterial Infections
1
Carcinoma, Non-Small-Cell Lung
1
Malaria
1
Malaria, Falciparum
1
Glioma
1

Who runs them

Industry 6 · Other 14

National Institute of Allergy and Infectious Diseases (NIAID) (4) · Glaxo Wellcome (4) · University of Oxford (2) · Emory University (2) · Baylor College of Medicine (1) · Medicines for Malaria Venture (1) · University of Texas Southwestern Medical Center (1) · Radboud University Medical Center (1)

Often tested with

Tested in the same studies.

Proguanil (4) · Azithromycin (3) · Dapsone (1) · Sulfadiazine (1) · Pyrimethamine (1) · Chloroquine (1) · Clindamycin (1) · Primaquine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Atovaquone.

Studies

Open first, then newest update. How each study uses Atovaquone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Given beside what is tested · 4 — Atovaquone is usual care or a partner of the new treatment

Codes

What other systems call Atovaquone · ClinicalTrials.gg INT008891

  • MeSH (NLM) D053626AtovaquoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Y883P1Z2LTATOVAQUONEConfirmed FDA, NLM, Wikidata
  • RxNorm 60212Confirmed FDA, Wikidata
  • Wikidata Q418179atovaquoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C28838AtovaquoneOne source FDA
  • DrugBank DB01117One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.